Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
Обзорная статья

The Tumor Microenvironment—A Metabolic Obstacle to NK Cells’ Activity

Joanna DomagałaDepartment of Immunology, Medical University of Warsaw, 02-097 Warsaw, PolandMieszko LachotaDepartment of Clinical Immunology, Medical University of Warsaw, 02-006 Warsaw, PolandMarta KłopotowskaDepartment of Clinical Immunology, Medical University of Warsaw, 02-006 Warsaw, PolandAgnieszka Graczyk‐JarzynkaDepartment of Immunology, Medical University of Warsaw, 02-097 Warsaw, PolandAntoni DomagałaDepartment of Urology, Holy Cross Cancer Center, 25-734 Kielce, PolandAndriy ZhylkoDepartment of Immunology, Medical University of Warsaw, 02-097 Warsaw, PolandKarolina SoroczyńskaDepartment of Immunology, Medical University of Warsaw, 02-097 Warsaw, PolandMagdalena WiniarskaDepartment of Immunology, Medical University of Warsaw, 02-097 Warsaw, Poland
2020en
ABI

Аннотация

NK cells have unique capabilities of recognition and destruction of tumor cells, without the requirement for prior immunization of the host. Maintaining tolerance to healthy cells makes them an attractive therapeutic tool for almost all types of cancer. Unfortunately, metabolic changes associated with malignant transformation and tumor progression lead to immunosuppression within the tumor microenvironment, which in turn limits the efficacy of various immunotherapies. In this review, we provide a brief description of the metabolic changes characteristic for the tumor microenvironment. Both tumor and tumor-associated cells produce and secrete factors that directly or indirectly prevent NK cell cytotoxicity. Here, we depict the molecular mechanisms responsible for the inhibition of immune effector cells by metabolic factors. Finally, we summarize the strategies to enhance NK cell function for the treatment of tumors.

Перевод пока недоступен

Идентификаторы

Цитирования и источники

Цитирований: 2Использованных источников: 0